There was new hope for Scottish patients with prostate cancer this week after cost regulators approved funding for the use of Ferring's Firmagon on the National Health Service. There was new hope for ...
Ferring’s Firmagon (degarelix) has been recommended for use by the NHS in England by the country’s cost-effectiveness watchdog NICE. It follows a protracted appeals process over 2014 guidance that had ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hgtc2g/firmagon) has announced the addition of GlobalData's new report ...
New data published in the December issue of the European Journal of Urology indicates improvement in overall survival (OS) and prostate specific antigen progression free survival (PSA PFS) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback